Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats

Départment d'Angiologie, Institut de Recherches Servier, Suresnes, France Submitted 14 May 2008 ; accepted in final form 22 September 2008 In spontaneously hypertensive rat (SHR) aorta, prostacyclin is an endothelium-derived contracting factor contributing to the endothelial dysfunction. This s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2008-11, Vol.295 (5), p.H2198-H2211
Hauptverfasser: Gomez, Elodie, Schwendemann, Cedric, Roger, Severine, Simonet, Serge, Paysant, Jerome, Courchay, Christine, Verbeuren, Tony J, Feletou, Michel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H2211
container_issue 5
container_start_page H2198
container_title American journal of physiology. Heart and circulatory physiology
container_volume 295
creator Gomez, Elodie
Schwendemann, Cedric
Roger, Severine
Simonet, Serge
Paysant, Jerome
Courchay, Christine
Verbeuren, Tony J
Feletou, Michel
description Départment d'Angiologie, Institut de Recherches Servier, Suresnes, France Submitted 14 May 2008 ; accepted in final form 22 September 2008 In spontaneously hypertensive rat (SHR) aorta, prostacyclin is an endothelium-derived contracting factor contributing to the endothelial dysfunction. This study was designed to determine whether the impairment of the prostacyclin response is influenced by aging and whether such a dysfunction is observed in platelets. Isometric tension was measured in aortic rings, and aggregation was studied in platelet-rich plasma taken from 3-, 6-, and 15-mo-old Wistar-Kyoto rats (WKY) and SHR. In aorta from 3- and 6-mo-old WKY, prostacyclin and beraprost [prostacyclin receptor (IP) agonists] produced relaxations that were enhanced by Triplion (thromboxane-prostanoid receptor antagonist). In 15-mo-old WKY, the relaxations to beraprost were maintained, but not those to prostacyclin. In SHR aorta, prostacyclin or beraprost produced no or minor relaxations, which, in younger SHR, were enhanced by Triplion. In both strains, the relaxations were inhibited by CAY-10441 (IP receptor antagonist). The relaxations to forskolin and isoproterenol were reduced with aging. When compared with those of WKY, the relaxations to isoproterenol were reduced in 3- but not in 6- or 15-mo-old SHR, whereas those to forskolin were consistently diminished at any given age. Whatever the age, prostacyclin and beraprost produced CAY-10441-sensitive inhibitions of ADP-induced platelet aggregation. Both agonists were more potent in SHR than in WKY. Therefore, in platelets from WKY and SHR, the IP receptor-dependent antiaggregant response is functional and maintained during aging. In aorta from WKY those responses are reduced by aging and, in SHR, are already compromised at 3 mo. This dysfunction of the IP receptor is only partially explained by a general dysfunction of the adenylate cyclase pathway. smooth muscle; prostacyclin receptor; endothelium-derived contracting factors; endothelial dysfunction; spontaneously hypertensive rats; Wistar-Kyoto rats Address for reprint requests and other correspondence: M. Félétou, Dépt. Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux 92150 Suresnes France (e-mail: michel.feletou{at}fr.netgrs.com )
doi_str_mv 10.1152/ajpheart.00507.2008
format Article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_proquest_miscellaneous_69761513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69761513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-57d62164e8b116a38000c8c3dbf8e4de06e33a1894ea0dea285114f93ea872d43</originalsourceid><addsrcrecordid>eNp1kFtLwzAYhoMoOg-_QJDihXfdcmjSFK9E1ImKoBPxKmTt160ja2uSovv3Zm4eELwKSZ735eVB6JDgPiGcDvSsnYK2vo8xx2mfYiw3UC_80Jhwlm2iHmaCxYIwvoN2nZvhAKaCbaMdImXAqeyhu7NJVU8iXRdRaxvndb7ITVVHFlzb1A5cFC66sV6vGKM9GPAuKm0zj55vXj6fH4cPkdXe7aOtUhsHB-tzDz1dXozOh_Ht_dX1-dltnCdS-pinhaBEJCDHhAjNZFiWy5wV41JCUgAWwJgmMktA4wI0lZyQpMwYaJnSImF76GTVGza_duC8mlcuB2N0DU3nlMhSQThhATz-A86aztZhm6I04ykLMwLEVlAeDDgLpWptNdd2oQhWS9XqS7X6VK2WqkPqaF3djedQ_GTWbgMwWAHTajJ9qyyodrpwVWOayeKnMaxQXA0pyZaJ0_8Tl50xI3j339FfSdUWJfsAw0OhFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229573216</pqid></control><display><type>article</type><title>Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Gomez, Elodie ; Schwendemann, Cedric ; Roger, Severine ; Simonet, Serge ; Paysant, Jerome ; Courchay, Christine ; Verbeuren, Tony J ; Feletou, Michel</creator><creatorcontrib>Gomez, Elodie ; Schwendemann, Cedric ; Roger, Severine ; Simonet, Serge ; Paysant, Jerome ; Courchay, Christine ; Verbeuren, Tony J ; Feletou, Michel</creatorcontrib><description>Départment d'Angiologie, Institut de Recherches Servier, Suresnes, France Submitted 14 May 2008 ; accepted in final form 22 September 2008 In spontaneously hypertensive rat (SHR) aorta, prostacyclin is an endothelium-derived contracting factor contributing to the endothelial dysfunction. This study was designed to determine whether the impairment of the prostacyclin response is influenced by aging and whether such a dysfunction is observed in platelets. Isometric tension was measured in aortic rings, and aggregation was studied in platelet-rich plasma taken from 3-, 6-, and 15-mo-old Wistar-Kyoto rats (WKY) and SHR. In aorta from 3- and 6-mo-old WKY, prostacyclin and beraprost [prostacyclin receptor (IP) agonists] produced relaxations that were enhanced by Triplion (thromboxane-prostanoid receptor antagonist). In 15-mo-old WKY, the relaxations to beraprost were maintained, but not those to prostacyclin. In SHR aorta, prostacyclin or beraprost produced no or minor relaxations, which, in younger SHR, were enhanced by Triplion. In both strains, the relaxations were inhibited by CAY-10441 (IP receptor antagonist). The relaxations to forskolin and isoproterenol were reduced with aging. When compared with those of WKY, the relaxations to isoproterenol were reduced in 3- but not in 6- or 15-mo-old SHR, whereas those to forskolin were consistently diminished at any given age. Whatever the age, prostacyclin and beraprost produced CAY-10441-sensitive inhibitions of ADP-induced platelet aggregation. Both agonists were more potent in SHR than in WKY. Therefore, in platelets from WKY and SHR, the IP receptor-dependent antiaggregant response is functional and maintained during aging. In aorta from WKY those responses are reduced by aging and, in SHR, are already compromised at 3 mo. This dysfunction of the IP receptor is only partially explained by a general dysfunction of the adenylate cyclase pathway. smooth muscle; prostacyclin receptor; endothelium-derived contracting factors; endothelial dysfunction; spontaneously hypertensive rats; Wistar-Kyoto rats Address for reprint requests and other correspondence: M. Félétou, Dépt. Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux 92150 Suresnes France (e-mail: michel.feletou{at}fr.netgrs.com )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00507.2008</identifier><identifier>PMID: 18820028</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Adenylyl Cyclases - metabolism ; Aging ; Aging - blood ; Aging - metabolism ; Animals ; Aorta - drug effects ; Aorta - metabolism ; Aorta - physiopathology ; Blood Platelets - drug effects ; Blood Platelets - metabolism ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Hypertension - blood ; Hypertension - metabolism ; Hypertension - physiopathology ; Male ; Muscular system ; Plasma ; Platelet Aggregation - drug effects ; Platelet Aggregation Inhibitors - pharmacology ; Prostaglandins I - blood ; Prostaglandins I - metabolism ; Rats ; Rats, Inbred SHR ; Rats, Inbred WKY ; Receptors, Epoprostenol - metabolism ; Receptors, Prostaglandin - metabolism ; Receptors, Thromboxane - metabolism ; Rodents ; Signal Transduction ; Studies ; Vasodilation - drug effects ; Vasodilator Agents - pharmacology ; Veins &amp; arteries</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2008-11, Vol.295 (5), p.H2198-H2211</ispartof><rights>Copyright American Physiological Society Nov 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-57d62164e8b116a38000c8c3dbf8e4de06e33a1894ea0dea285114f93ea872d43</citedby><cites>FETCH-LOGICAL-c488t-57d62164e8b116a38000c8c3dbf8e4de06e33a1894ea0dea285114f93ea872d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,3043,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18820028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gomez, Elodie</creatorcontrib><creatorcontrib>Schwendemann, Cedric</creatorcontrib><creatorcontrib>Roger, Severine</creatorcontrib><creatorcontrib>Simonet, Serge</creatorcontrib><creatorcontrib>Paysant, Jerome</creatorcontrib><creatorcontrib>Courchay, Christine</creatorcontrib><creatorcontrib>Verbeuren, Tony J</creatorcontrib><creatorcontrib>Feletou, Michel</creatorcontrib><title>Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>Départment d'Angiologie, Institut de Recherches Servier, Suresnes, France Submitted 14 May 2008 ; accepted in final form 22 September 2008 In spontaneously hypertensive rat (SHR) aorta, prostacyclin is an endothelium-derived contracting factor contributing to the endothelial dysfunction. This study was designed to determine whether the impairment of the prostacyclin response is influenced by aging and whether such a dysfunction is observed in platelets. Isometric tension was measured in aortic rings, and aggregation was studied in platelet-rich plasma taken from 3-, 6-, and 15-mo-old Wistar-Kyoto rats (WKY) and SHR. In aorta from 3- and 6-mo-old WKY, prostacyclin and beraprost [prostacyclin receptor (IP) agonists] produced relaxations that were enhanced by Triplion (thromboxane-prostanoid receptor antagonist). In 15-mo-old WKY, the relaxations to beraprost were maintained, but not those to prostacyclin. In SHR aorta, prostacyclin or beraprost produced no or minor relaxations, which, in younger SHR, were enhanced by Triplion. In both strains, the relaxations were inhibited by CAY-10441 (IP receptor antagonist). The relaxations to forskolin and isoproterenol were reduced with aging. When compared with those of WKY, the relaxations to isoproterenol were reduced in 3- but not in 6- or 15-mo-old SHR, whereas those to forskolin were consistently diminished at any given age. Whatever the age, prostacyclin and beraprost produced CAY-10441-sensitive inhibitions of ADP-induced platelet aggregation. Both agonists were more potent in SHR than in WKY. Therefore, in platelets from WKY and SHR, the IP receptor-dependent antiaggregant response is functional and maintained during aging. In aorta from WKY those responses are reduced by aging and, in SHR, are already compromised at 3 mo. This dysfunction of the IP receptor is only partially explained by a general dysfunction of the adenylate cyclase pathway. smooth muscle; prostacyclin receptor; endothelium-derived contracting factors; endothelial dysfunction; spontaneously hypertensive rats; Wistar-Kyoto rats Address for reprint requests and other correspondence: M. Félétou, Dépt. Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux 92150 Suresnes France (e-mail: michel.feletou{at}fr.netgrs.com )</description><subject>Adenylyl Cyclases - metabolism</subject><subject>Aging</subject><subject>Aging - blood</subject><subject>Aging - metabolism</subject><subject>Animals</subject><subject>Aorta - drug effects</subject><subject>Aorta - metabolism</subject><subject>Aorta - physiopathology</subject><subject>Blood Platelets - drug effects</subject><subject>Blood Platelets - metabolism</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hypertension - blood</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Muscular system</subject><subject>Plasma</subject><subject>Platelet Aggregation - drug effects</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>Prostaglandins I - blood</subject><subject>Prostaglandins I - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>Rats, Inbred WKY</subject><subject>Receptors, Epoprostenol - metabolism</subject><subject>Receptors, Prostaglandin - metabolism</subject><subject>Receptors, Thromboxane - metabolism</subject><subject>Rodents</subject><subject>Signal Transduction</subject><subject>Studies</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Veins &amp; arteries</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kFtLwzAYhoMoOg-_QJDihXfdcmjSFK9E1ImKoBPxKmTt160ja2uSovv3Zm4eELwKSZ735eVB6JDgPiGcDvSsnYK2vo8xx2mfYiw3UC_80Jhwlm2iHmaCxYIwvoN2nZvhAKaCbaMdImXAqeyhu7NJVU8iXRdRaxvndb7ITVVHFlzb1A5cFC66sV6vGKM9GPAuKm0zj55vXj6fH4cPkdXe7aOtUhsHB-tzDz1dXozOh_Ht_dX1-dltnCdS-pinhaBEJCDHhAjNZFiWy5wV41JCUgAWwJgmMktA4wI0lZyQpMwYaJnSImF76GTVGza_duC8mlcuB2N0DU3nlMhSQThhATz-A86aztZhm6I04ykLMwLEVlAeDDgLpWptNdd2oQhWS9XqS7X6VK2WqkPqaF3djedQ_GTWbgMwWAHTajJ9qyyodrpwVWOayeKnMaxQXA0pyZaJ0_8Tl50xI3j339FfSdUWJfsAw0OhFQ</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Gomez, Elodie</creator><creator>Schwendemann, Cedric</creator><creator>Roger, Severine</creator><creator>Simonet, Serge</creator><creator>Paysant, Jerome</creator><creator>Courchay, Christine</creator><creator>Verbeuren, Tony J</creator><creator>Feletou, Michel</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20081101</creationdate><title>Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats</title><author>Gomez, Elodie ; Schwendemann, Cedric ; Roger, Severine ; Simonet, Serge ; Paysant, Jerome ; Courchay, Christine ; Verbeuren, Tony J ; Feletou, Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-57d62164e8b116a38000c8c3dbf8e4de06e33a1894ea0dea285114f93ea872d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adenylyl Cyclases - metabolism</topic><topic>Aging</topic><topic>Aging - blood</topic><topic>Aging - metabolism</topic><topic>Animals</topic><topic>Aorta - drug effects</topic><topic>Aorta - metabolism</topic><topic>Aorta - physiopathology</topic><topic>Blood Platelets - drug effects</topic><topic>Blood Platelets - metabolism</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hypertension - blood</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Muscular system</topic><topic>Plasma</topic><topic>Platelet Aggregation - drug effects</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>Prostaglandins I - blood</topic><topic>Prostaglandins I - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>Rats, Inbred WKY</topic><topic>Receptors, Epoprostenol - metabolism</topic><topic>Receptors, Prostaglandin - metabolism</topic><topic>Receptors, Thromboxane - metabolism</topic><topic>Rodents</topic><topic>Signal Transduction</topic><topic>Studies</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gomez, Elodie</creatorcontrib><creatorcontrib>Schwendemann, Cedric</creatorcontrib><creatorcontrib>Roger, Severine</creatorcontrib><creatorcontrib>Simonet, Serge</creatorcontrib><creatorcontrib>Paysant, Jerome</creatorcontrib><creatorcontrib>Courchay, Christine</creatorcontrib><creatorcontrib>Verbeuren, Tony J</creatorcontrib><creatorcontrib>Feletou, Michel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gomez, Elodie</au><au>Schwendemann, Cedric</au><au>Roger, Severine</au><au>Simonet, Serge</au><au>Paysant, Jerome</au><au>Courchay, Christine</au><au>Verbeuren, Tony J</au><au>Feletou, Michel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>295</volume><issue>5</issue><spage>H2198</spage><epage>H2211</epage><pages>H2198-H2211</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>Départment d'Angiologie, Institut de Recherches Servier, Suresnes, France Submitted 14 May 2008 ; accepted in final form 22 September 2008 In spontaneously hypertensive rat (SHR) aorta, prostacyclin is an endothelium-derived contracting factor contributing to the endothelial dysfunction. This study was designed to determine whether the impairment of the prostacyclin response is influenced by aging and whether such a dysfunction is observed in platelets. Isometric tension was measured in aortic rings, and aggregation was studied in platelet-rich plasma taken from 3-, 6-, and 15-mo-old Wistar-Kyoto rats (WKY) and SHR. In aorta from 3- and 6-mo-old WKY, prostacyclin and beraprost [prostacyclin receptor (IP) agonists] produced relaxations that were enhanced by Triplion (thromboxane-prostanoid receptor antagonist). In 15-mo-old WKY, the relaxations to beraprost were maintained, but not those to prostacyclin. In SHR aorta, prostacyclin or beraprost produced no or minor relaxations, which, in younger SHR, were enhanced by Triplion. In both strains, the relaxations were inhibited by CAY-10441 (IP receptor antagonist). The relaxations to forskolin and isoproterenol were reduced with aging. When compared with those of WKY, the relaxations to isoproterenol were reduced in 3- but not in 6- or 15-mo-old SHR, whereas those to forskolin were consistently diminished at any given age. Whatever the age, prostacyclin and beraprost produced CAY-10441-sensitive inhibitions of ADP-induced platelet aggregation. Both agonists were more potent in SHR than in WKY. Therefore, in platelets from WKY and SHR, the IP receptor-dependent antiaggregant response is functional and maintained during aging. In aorta from WKY those responses are reduced by aging and, in SHR, are already compromised at 3 mo. This dysfunction of the IP receptor is only partially explained by a general dysfunction of the adenylate cyclase pathway. smooth muscle; prostacyclin receptor; endothelium-derived contracting factors; endothelial dysfunction; spontaneously hypertensive rats; Wistar-Kyoto rats Address for reprint requests and other correspondence: M. Félétou, Dépt. Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux 92150 Suresnes France (e-mail: michel.feletou{at}fr.netgrs.com )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18820028</pmid><doi>10.1152/ajpheart.00507.2008</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2008-11, Vol.295 (5), p.H2198-H2211
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_miscellaneous_69761513
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adenylyl Cyclases - metabolism
Aging
Aging - blood
Aging - metabolism
Animals
Aorta - drug effects
Aorta - metabolism
Aorta - physiopathology
Blood Platelets - drug effects
Blood Platelets - metabolism
Disease Models, Animal
Dose-Response Relationship, Drug
Hypertension - blood
Hypertension - metabolism
Hypertension - physiopathology
Male
Muscular system
Plasma
Platelet Aggregation - drug effects
Platelet Aggregation Inhibitors - pharmacology
Prostaglandins I - blood
Prostaglandins I - metabolism
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Receptors, Epoprostenol - metabolism
Receptors, Prostaglandin - metabolism
Receptors, Thromboxane - metabolism
Rodents
Signal Transduction
Studies
Vasodilation - drug effects
Vasodilator Agents - pharmacology
Veins & arteries
title Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T13%3A36%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aging%20and%20prostacyclin%20responses%20in%20aorta%20and%20platelets%20from%20WKY%20and%20SHR%20rats&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Gomez,%20Elodie&rft.date=2008-11-01&rft.volume=295&rft.issue=5&rft.spage=H2198&rft.epage=H2211&rft.pages=H2198-H2211&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/10.1152/ajpheart.00507.2008&rft_dat=%3Cproquest_highw%3E69761513%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229573216&rft_id=info:pmid/18820028&rfr_iscdi=true